Viewing StudyNCT06297226



Ignite Creation Date: 2024-05-06 @ 8:12 PM
Last Modification Date: 2024-10-26 @ 3:23 PM
Study NCT ID: NCT06297226
Status: RECRUITING
Last Update Posted: 2024-07-12
First Post: 2024-02-28

Brief Title: Study of BMS-986393 a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor: Juno Therapeutics Inc a Bristol-Myers Squibb Company
Organization: Juno Therapeutics Inc a Bristol-Myers Squibb Company

Conditions & Keywords Data

Conditions:
Name
Multiple Myeloma
Keywords:
Name View
RRMM View
Relapsed or Refractory Multiple Myeloma View
Multiple Myeloma View
BMS-986393 View
CAR T Cell Therapy View